Ingmar Rompen (@ingmarfrompen) 's Twitter Profile
Ingmar Rompen

@ingmarfrompen

Surgeon

ID: 1629496450882195457

calendar_today25-02-2023 15:00:18

26 Tweet

40 Followers

35 Following

Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

Early surgery 🤜🤛 Endoscopy first in Chronic Pancreatitis: long term outcomes (100 months FU) 😓 Pain score / complete relief 😅 and patient satisfaction all favor surgery 🪡 Is early surgery the best approach?! Comments? 🧐 jamanetwork.com/journals/jamas…

Early surgery 🤜🤛 Endoscopy first in Chronic Pancreatitis: long term outcomes (100 months FU)

😓 Pain score / complete relief 😅 and patient satisfaction all favor surgery 

🪡 Is early surgery the best approach?! Comments? 🧐

jamanetwork.com/journals/jamas…
Thomas Hank, MD (@thomashankmd) 's Twitter Profile Photo

#WorldPancreaticCancerDay 2024 in Heidelberg for our patients and relatives with special lectures and workshops on State of the art treatment 🧑‍⚕️ Nutritional support 🥦 Glycemic control and enzymes 💊 Psycho-Oncology ☯️ #keepfighting 💜💜💜 Heidelberg Pancreatic Surgery (HPS) Christoph Michalski

#WorldPancreaticCancerDay 2024 in Heidelberg for our patients and relatives with special lectures and workshops on
State of the art treatment 🧑‍⚕️
Nutritional support 🥦
Glycemic control and enzymes 💊
Psycho-Oncology ☯️

#keepfighting 💜💜💜

<a href="/surgery_hps/">Heidelberg Pancreatic Surgery (HPS)</a> <a href="/cw_michalski/">Christoph Michalski</a>
Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

Reoperation for pancreatic fistula 🐳 🤜🤛 Completion pancreatectomy or pancreas-preserving procedures ?! 💦 Drainage / wirsungostomy most used 44% vs. Completion panc 37% 😱 Mortality as high as 67%! 👀 What is your policy? Thoughts? 🆓 paper 👉 hpbonline.org/article/S1365-…

Reoperation for pancreatic fistula 🐳

🤜🤛 Completion pancreatectomy or pancreas-preserving procedures ?!

💦 Drainage / wirsungostomy most used 44% vs. Completion panc 37%

😱 Mortality as high as 67%! 

👀 What is your policy? Thoughts? 

🆓 paper 👉 hpbonline.org/article/S1365-…
Marc Besselink (@marcbesselink) 's Twitter Profile Photo

2025 Multi-Societal #European #Guideline on #PancreaticCancer ✅ Meeting with our 39 amazing Research leads to discuss progress and any issues ▶️ 30 Societies ▶️ 13 Working groups ▶️ Focus on knowledge gaps E-AHPBA European Society of Surgical Oncology (ESSO) my_UEG ISGPS ESGE ESMO - Eur. Oncology a.m.o.

2025 Multi-Societal #European #Guideline on #PancreaticCancer 
✅ Meeting with our 39 amazing Research leads to discuss progress and any issues

▶️ 30 Societies
▶️ 13 Working groups
▶️ Focus on knowledge gaps

<a href="/EAHPBA/">E-AHPBA</a> <a href="/ESSOnews/">European Society of Surgical Oncology (ESSO)</a> <a href="/my_ueg/">my_UEG</a> <a href="/ISGPS_news/">ISGPS</a> <a href="/ESGE_news/">ESGE</a> <a href="/myESMO/">ESMO - Eur. Oncology</a> a.m.o.
Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

Long term natural history of BD IPMN 🍇 beyond 10 years of follow-up 🧐 316 patients 🇺🇸 median FU 13 years 🚨 At 10 years 24% WF / 8% Malignancy 📈 Risk of cancer overall 9X population 🎞️ Dynamic evaluation needed to stratify risk! journals.lww.com/annalsofsurger…

Long term natural history of BD IPMN 🍇 beyond 10 years of follow-up

🧐 316 patients 🇺🇸 median FU 13 years

🚨 At 10 years 24% WF / 8% Malignancy

📈 Risk of cancer overall 9X population

🎞️ Dynamic evaluation needed to stratify risk! 

journals.lww.com/annalsofsurger…
BJS (@bjsurgery) 's Twitter Profile Photo

Mural nodules and prevalence of high-grade dysplasia in branch duct intraductal papillary mucinous neoplasm of the pancreas undergoing resection ➡️ doi.org/10.1093/bjs/zn… In this cohort of mural module within BD-IPMN, we thoroughly examined the location of HGD/IC relative to

Mural nodules and prevalence of high-grade dysplasia in branch duct intraductal papillary mucinous neoplasm of the pancreas undergoing resection
➡️ doi.org/10.1093/bjs/zn…

In this cohort of mural module within BD-IPMN, we thoroughly examined the location of HGD/IC relative to
Thomas Stoop (@tfstoop) 's Twitter Profile Photo

PVR 1-2 vs 3-4 during pancreatoduodenectomy for resectable #PDAC with venous involvement? In Annals of Surgery our observational study with 357 patients🇸🇪🇯🇵🇳🇱🇺🇸: 📌PVR type NOT associated with OS, locoregional recurrence & major morbidity ➡️ surgeon’s personal preference

PVR 1-2 vs 3-4 during pancreatoduodenectomy for resectable #PDAC with venous involvement? 

In <a href="/AnnalsofSurgery/">Annals of Surgery</a> our observational study with 357 patients🇸🇪🇯🇵🇳🇱🇺🇸: 

📌PVR type NOT associated with OS, locoregional recurrence &amp; major morbidity 

➡️ surgeon’s personal preference
Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

⏰ Temporary Portal Vein Bypass for Resection of Pancreatic Neoplasms 🇩🇪 63 consecutive LAPC cases 🚨 Severe complications 25% / No liver failure / mortality 6% 👷‍♀️Decision according to anatomy + extent arterial involvement 🫵 Your practice?! journals.lww.com/annalsofsurger…

Annals of Surgery (@annalsofsurgery) 's Twitter Profile Photo

What’s New and Interesting at Annals: Cost-analysis of implementing robot-assisted versus open pancreatoduodenectomy from Julia Menso Michiel Francken Marc Besselink @AmsterdamUMC #roboticsurgery #roboticpancreatoduodenectomy #costanalysis journals.lww.com/annalsofsurger…

What’s New and Interesting at Annals: Cost-analysis of implementing robot-assisted versus open pancreatoduodenectomy from <a href="/julia_menso/">Julia Menso</a> <a href="/MichielFrancken/">Michiel Francken</a> <a href="/MarcBesselink/">Marc Besselink</a> @AmsterdamUMC #roboticsurgery #roboticpancreatoduodenectomy #costanalysis 

journals.lww.com/annalsofsurger…
JAMA Surgery (@jamasurgery) 's Twitter Profile Photo

Early surgery results in better pain relief, higher patient satisfaction, and fewer reinterventions compared to an endoscopy-first approach for patients with painful chronic pancreatitis with dilated pancreatic duct. ja.ma/4i221at

Early surgery results in better pain relief, higher patient satisfaction, and fewer reinterventions compared to an endoscopy-first approach for patients with painful chronic pancreatitis with dilated pancreatic duct. ja.ma/4i221at
Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

Is there a role for neoadjuvant chemo for 🍇 invasive IPMN ?! 🌎 1k resected only 7% after NAT 👍 BR / LAPC no worse OS after NAT 🧪 CA19.9 indicates “biological” treatment effect 👉journals.lww.com/annalsofsurger…

Is there a role for neoadjuvant chemo for 🍇 invasive IPMN ?! 

🌎 1k resected only 7% after NAT 

👍 BR / LAPC no worse OS after NAT

🧪 CA19.9 indicates “biological” treatment effect 

👉journals.lww.com/annalsofsurger…
Hiroyuki Ishida (@hiro_ishida_md) 's Twitter Profile Photo

Published in @HPBjournal, our 🌎 survey study on surgical management of pancreatic neck/body cancer with venous involvement 🔍: 📝 222 surgeons, 49 countries, 6 continents 📍 Heterogenity in surgical management strategies ⚠️ Need for prospective studies & guidelines

Published in <a href="/hpbjournal/">@HPBjournal</a>, our 🌎 survey study on surgical management of pancreatic neck/body cancer with venous involvement 🔍:

📝 222 surgeons, 49 countries, 6 continents

📍 Heterogenity in surgical management strategies

⚠️ Need for prospective studies &amp; guidelines
Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

March Issue: Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived #PancreaticCancer : An International Multicenter Study Joseph R. Habib rdcu.be/efnIm David Caba MD,MS,MPH,FACS Syed A. Ahmad

March Issue: Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived #PancreaticCancer : An International Multicenter Study  <a href="/J_habib1/">Joseph R. Habib</a>
 
rdcu.be/efnIm

<a href="/DavidCabaMD/">David Caba MD,MS,MPH,FACS</a>
<a href="/SyedAAhmad5/">Syed A. Ahmad</a>
Dejan Radenkovic (@dejanradenkovi2) 's Twitter Profile Photo

Full Circle Moment From a postdoctoral fellow in 2007 to Visiting Professor —an incredible honor to give my Inauguration Lecture at the University of Heidelberg Heidelberg Pancreatic Surgery (HPS)! Grateful and excited for what’s ahead. Christoph Michalski Benedict Kinny-Köster Thomas Hank, MD Mohammed Al-Saeedi

Full Circle Moment 
From a postdoctoral fellow in 2007 to Visiting Professor —an incredible honor to give my Inauguration Lecture at the University of Heidelberg <a href="/surgery_hps/">Heidelberg Pancreatic Surgery (HPS)</a>! Grateful and excited for what’s ahead.
<a href="/cw_michalski/">Christoph Michalski</a>  <a href="/bkinnykoester/">Benedict Kinny-Köster</a> <a href="/ThomasHankMD/">Thomas Hank, MD</a> <a href="/Mo_Saeedi_Surg/">Mohammed Al-Saeedi</a>
Annals of Surgery (@annalsofsurgery) 's Twitter Profile Photo

Pancreatic cancer patients aren't all the same. 🧬 The PANAMA score identifies who really benefits from post-op chemo after FOLFIRINOX—saving some from unnecessary treatment. 🔗journals.lww.com/annalsofsurger…

Annals of Surgery (@annalsofsurgery) 's Twitter Profile Photo

📊 Smarter stratification for pancreatic cancer care: This multicenter study validated the PANAMA score to predict both survival and who should get chemo after FOLFIRINOX and surgery. 🔗journals.lww.com/annalsofsurger…

Giovanni Marchegiani (@gio_marchegiani) 's Twitter Profile Photo

Hora est! 🎓 PhD cerimony in 🇳🇱 is just something different… with two ⭐️⭐️ like Ammar Asrar Javed, MD PhD 🇺🇸 and Joe Habib then it’s glorious! Thank you for having me in this fantastic IPMN journey between 🇺🇸 and 🇪🇺 Looking forward to the next steps (and to be as tall as Marc Besselink 😂)

Hora est! 🎓 PhD cerimony in 🇳🇱 is just something different… with two ⭐️⭐️ like <a href="/ammar_asrar/">Ammar Asrar Javed, MD PhD 🇺🇸</a> and Joe Habib then it’s glorious! 

Thank you for having me in this fantastic IPMN journey between 🇺🇸 and 🇪🇺

Looking forward to the next steps (and to be as tall as <a href="/MarcBesselink/">Marc Besselink</a> 😂)
Stefano Crippa (@stefanocrippa6) 's Twitter Profile Photo

🇮🇹CASSANDRA TRIAL🇮🇹 Phase 3 RCT: Neoadjuvant PAXG vs mFOLFIRINOX in resectable/BR #PDAC 💥PAXG shows: ✅⬆️EFS ✅⬆️Path response ✅Suggestion of ⬆️OS ✅Same toxicity PAXG superior to mFOLFIRINOX? IHPBA EPC-Europ Pancr Club E-AHPBA OncoAlert Pancreatic Cancer Action Oncoinfo SoMe4HPB

🇮🇹CASSANDRA TRIAL🇮🇹

Phase 3 RCT: Neoadjuvant PAXG vs mFOLFIRINOX in resectable/BR #PDAC 

💥PAXG shows:
✅⬆️EFS
✅⬆️Path response
✅Suggestion of ⬆️OS 
✅Same toxicity

PAXG superior to mFOLFIRINOX? 

<a href="/IHPBA/">IHPBA</a> <a href="/EurPancClub/">EPC-Europ Pancr Club</a> <a href="/EAHPBA/">E-AHPBA</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/OfficialPCA/">Pancreatic Cancer Action</a> <a href="/Oncoinfo_it/">Oncoinfo</a> <a href="/hpb_so/">SoMe4HPB</a>